Effectiveness of the RISE Intervention

Sponsor
UMC Utrecht (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT06124248
Collaborator
(none)
197
21
2
22.5
9.4
0.4

Study Details

Study Description

Brief Summary

Study aim:

To determine the effectiveness of the RISE intervention on reducing sedentary behaviour after discharge from acute hospital care in community dwelling people with a first-ever stroke, who have a sedentary movement behavioural pattern (so called 'sedentary prolongers' and 'sedentary movers') in comparison to usual care, at the end of the intervention period (T1).

Who can participate? People aged over 18, who return home after acute care with a first-ever stroke, who are independent in walking with or without a walking aid, will be included in the RISE intervention study.

What does the study involve? In this clinical randomized controlled trial, participants with first-ever stroke and a sedentary movement pattern will be included and randomly assigned to either the experimental group who will receive RISE intervention and usual care or the control group who will receive usual care. Primary and secondary outcome will be measured at baseline, post-treatment and six, nine and 12 months post-randomisation.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: RISE intervention
N/A

Detailed Description

Background and study aims Background: People who have suffered a stroke are at high risk of functional decline, recurrent stroke and premature mortality. High amounts of sedentary behaviour, accumulated in prolonged bouts and low amounts of moderate to vigorous physical activity increase the risk of cardiovascular disease. Based on earlier research it is expected that a healthier balance in the 24h activity pattern (sedentary time, physical activity and sleep) reduces the risk of a second cardiovascular event. To support patients with stroke to strike the balance in their 24h activity pattern, a behavioural change coaching intervention focusing on reducing and interrupting their sedentary time was designed. A pilot study has been performed, and the RISE intervention seems feasible in reducing sedentary behaviour in people after stroke.

Study aim: To determine the effectiveness of the RISE intervention on reducing sedentary behaviour after discharge from acute hospital care in community dwelling people with a first-ever stroke, who have a sedentary movement behavioural pattern (so called 'sedentary prolongers' and 'sedentary movers') in comparison to usual care, at the end of the intervention period (T1).

Who can participate? People aged over 18, who return home after acute care with a first-ever stroke, who are independent in walking with or without a walking aid, will be included in the RISE intervention study.

What does the study involve? In this clinical randomized controlled trial, participants with first-ever stroke and a sedentary movement pattern will be included and randomly assigned to either the experimental group who will receive RISE intervention and usual care or the control group who will receive usual care. Primary and secondary outcome will be measured at baseline, post-treatment and six, nine and 12 months post-randomisation.

What are the possible benefits and risks of participating? The possible benefits of participating in the study are: 1) insights in own movement behaviour and 2) (if someone is randomized to the RISE intervention group) the RISE intervention may help to reduce sedentary time, which may lower the risk on recurrent stroke.

The possible burden of participating in the study is that it will cost time to fulfill all questionnaires and other measurements. It will take about 45 minutes per follow-up measurement. The burden and risk of participating in the RISE intervention are considered low. The participants will receive a blended coaching intervention to reduce and interrupt their sedentary behaviour. The blended intervention includes ten face-to-face or online sessions of a primary care physiotherapist, wearing an activity monitor during the intervention period, and support from the smartphone application. During the intervention people will be encouraged to sit less and move more. The participant will participate in a baseline and post intervention measurements. This includes wearing an activity monitor, questionnaires and performing physical tests. All measurements are non-invasive. Participants can shower and perform all other daily activities while wearing the activity monitor. The other measurements will take about 3.5 hours in total, and will be carried out online or at people's homes. Included participants are physically capable of performing these physical activities and are coached by a physiotherapist. Therefore, the risk involved in participating is low. Additional burden of the intervention is low since visits of the physiotherapist will be at home or online.

Where is the study run from? Department of Rehabilitation Physiotherapy Science and Sport, University Medical Center (UMC) Utrecht, Utrecht University, Netherlands

When is the study starting and how long is it expected to run for? September 2022 to September 2026

Who is funding the study? National Directorate for Practice-oriented Research SIA (Regieorgaan Praktijkgericht Onderzoek SIA), Netherlands SIA RAAK PRO

Who is the main contact?

  1. Camille Biemans, c.f.m.biemans@umcutrecht.nl (public)

  2. Dr. Martijn Pisters, m.f.pisters@umcutrecht.nl (scientific)

Study Design

Study Type:
Interventional
Anticipated Enrollment :
197 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Investigator)
Masking Description:
The investigator who carries out the T1 follow-up measurement (end of the intervention period), will be blinded for treatment allocation.
Primary Purpose:
Treatment
Official Title:
Effectiveness of the RISE Intervention to Reduce and Interrupt Sedentary Behaviour in Community Dwelling Sedentary People After First-ever Stroke
Anticipated Study Start Date :
Nov 15, 2023
Anticipated Primary Completion Date :
Jan 1, 2025
Anticipated Study Completion Date :
Oct 1, 2025

Arms and Interventions

Arm Intervention/Treatment
Experimental: Experimental group

RISE intervention and usual care

Behavioral: RISE intervention
The RISE intervention: a 15-weeks blended behavioral intervention, where a primary care physiotherapist coaches participants on striking the balance in their 24h activity pattern, with a focus on reducing and interrupting their sedentary time. This will subsequently lead to an increase in physical activity. Next to that, insights into their personal sleep pattern, sleep hygiene rules and advices will be provided. Primary care physiotherapists coach people with a first-ever stroke in their home setting by using behavior change techniques and the RISE eCoaching system. The RISE eCoaching system consists of 1) an activity monitor, 2) a smartphone application that provides real-time feedback and contains e-learning modules, 3) a monitoring dashboard for the physiotherapist. Participants receive participatory support from someone from their social network (e.g., partner or close friend) who joins them in the intervention (see image 1).

No Intervention: Control group

Usual care

Outcome Measures

Primary Outcome Measures

  1. Sedentary behaviour [Baseline (T0) - One year post-randomisation (T4)]

    Amount of sedentary time objectively measured with ActivPAL (activity monitor)

Secondary Outcome Measures

  1. Fragmentation of sedentary behaviour [Baseline (T0) - One year post-randomisation (T4)]

    The fragmentation index of sedentary behaviour objectively measured with ActivPAL (PAL Technologies Ltd, Glasgow, United Kingdom, activity monitor).

  2. Sedentary time interruption [Baseline (T0) - One year post-randomisation (T4)]

    The sedentary time interruption (amount of sedentary bouts, average sedentary bout duration, percentage of sedentary time accumulated in bouts over 30 min and 60 min) will be objectively measured with ActivPAL (PAL Technologies Ltd, Glasgow, United Kingdom, activity monitor).

  3. Amount of light physical activity [Baseline (T0) - One year post-randomisation (T4)]

    Amount of light physical activity objectively measured with ActivPAL (activity monitor)

  4. Amount of moderate to vigorous physical activity [Baseline (T0) - One year post-randomisation (T4)]

    Amount of moderate to vigorous physical activity objectively measured with ActivPAL (activity monitor)

  5. Self-management [Baseline (T0) - One year post-randomisation (T4)]

    Self-management measured with questionnaire: Patient Activation Measure (PAM). The Pam 13-Dutch is a reliable 13-item instrument and assesses patient (or consumer) self-reported knowledge, skills and confidence for self-management of one's health or chronic condition. The answering categories per item are 4-point Likert scales, ranging from totally disagree to totally agree and 'non applicable'. A higher score (range 1-100) indicates a higher level of self-management.

  6. Self-efficacy [Baseline (T0) - One year post-randomisation (T4)]

    Self-efficacy measured with questionnaire: Self-Efficacy Symptom Management Scale (SESx). This questionnaire consists of 13 items scored on a 10-point scale ranging from 'not confident at all' to 'completely confident'. A higher score indicating higher self-efficacy.

  7. Sedentary behaviour (long term) [Baseline (T0) - One year post-randomisation (T4)]

    Amount of sedentary time objectively measured with ActivPAL

  8. End-user satisfaction of the RISE eCoaching system [Three months post-randomisation (T1)]

    End-user satisfaction of the RISE eCoaching system will be measured with questionnaire: End-User Computing Satisfaction (EUCS). The EUCS is a 12-item questionnaire to measure end-use computing satisfaction of the (experimental group) participant and physiotherapists about usage of the RISE eCoaching system. All items are scored with a 5-point Likert scale ('almost never' to 'almost always').

  9. Acceptability of the RISE eCoaching system [Three months post-randomisation (T1)]

    Acceptability of the RISE eCoaching system will be measured with questionnaire: Post-Study System Usability Questionnaire (PSSUQ). The PSSUQ is a 19-item instrument that assesses the perceived satisfaction of a user with a system, in this case the RISE eCoaching system.

  10. Usability of the RISE eCoaching system [Three months post-randomisation (T1)]

    Usability of the RISE eCoaching system will be measured with questionnaire: System Usability Scale (SUS). The SUS is a questionnaire that measures the perceived usability of the m-health part of the intervention by posing 10 statements which the participant can rate on a 5-points Likert scale ('completely agree' to 'completely disagree'). The score ranges from 0-100, with a higher score indicating a higher perceived usability.

  11. Sleep quality [Baseline (T0) - One year post-randomisation (T4)]

    Sleep quality will be objectively measured with the Emfit QS Sleep tracker (Emfit Ltd, Vaajakoski, Finland; 542 3 70 3 1.4 mm). Next to the Emfit QS, experienced sleep quality is measured with the Pittsburgh Sleep Quality Index (PSQI). ThePSQI is a 19-item self-reported questionnaire about experienced sleep quality in the past month.

  12. Sleep quantity [Baseline (T0) - One year post-randomisation (T4)]

    Sleep quantity will be objectively measured with the Emfit QS Sleep tracker (Emfit Ltd, Vaajakoski, Finland; 542 3 70 3 1.4 mm)

  13. Level of fatigue [Baseline (T0) - One year post-randomisation (T4)]

    Level of fatigue will be measured with questionnaire: Fatigue Severity Scale-7 (FSS-7). The items are asked about the past few weeks and relate to the perceived severity of fatigue in different daily situations. The FSS-7 measures chronic fatigue in 7 items with a 7-point likert scale (ranging from 'totally disagree' to 'totally agree'). The final score is the mean of the 7 item scores. A final score of ≥4 indicates that the severity of fatigue has a medium to high impact on daily life.

  14. Physical functioning and participation [Baseline (T0) - Three months post-randomisation (T1)]

    Physical functioning and participation will be measured using the Short Physical Performance Battery (SPPB). The Short Physical Performance Battery (SPPB) is an objective assessment tool for evaluating lower extremity functioning in older persons, which gives insight in someone's walking speed, balance and leg strength. The SPPB consists of a balance test, a gait speed test and a chair stand test, of which each item is score with 1, 2 or 4 points. The maximal total score is 12, in which a higher score indicates better lower extremity functioning.

  15. Stroke physical impact [Baseline (T0) - One year post-randomisation (T4)]

    Stroke physical impact will be measured with questionnaire: Stroke Impact Scale (SIS). This questionnaire has 37 questions in 5 domains (strength, hand function, activities daily living /Instrumental activities daily living, mobility and participation/ role and function). In this study, the domain 'activities daily living' is used. These questions are answered on a 5-point Likert scale ranging from 1, negative (e.g. 'no strength at all' or 'extremely difficult'), to 5 (e.g. 'a lot of strength' or 'not difficult at all').

  16. 24h activity pattern (sedentary behaviour, physical activity and sleep) [Baseline (T0) - One year post-randomisation (T4)]

    Change in sleep quantity, amount of time spent sedentary, amount of time spent in light physical activity and amount of time spent moderate to vigorous physical activity will be combined to report the 24h activity pattern.

Other Outcome Measures

  1. Patient characteristics [Baseline (T0)]

    Patient characteristics will be measured with an intake questionnaire ((age, gender, education level, living situation (number of persons in the household), comorbidities, measured with CIRS (50), stroke characteristics (type of stroke, side of stroke, time since stroke) and vascular risk factors (coronary artery disease, AF, diabetes, hypertension, clinical obesity, smoking and alcohol use, hyperlipidemia).

  2. Walking speed [Baseline (T0)]

    Walking speed will be measured with the 5 meter walk test (5MWT) in which the participants is asked to walk 5 meters 3 times. Form the average duration of these three times the walking speed is calculated in meters per second.

  3. Cognitive functioning [Baseline (T0)]

    Cognitive functioning will be assessed using the Montreal Cognitive Assessment (MoCA). MoCA assesses eight domains of cognitive functioning with small tasks. The scores range from 0-30, a score of <26 indicates impaired cognitive function.

  4. Mental health status [Baseline (T0) - One year post-randomisation (T4)]

    Mental health status will be measured with the Hospital Anxiety and Depression Scale (HADS). The HADS is a short questionnaire of 14 items with a 4-point Likert scale. A higher score indicates more mental health problems.

  5. Patients' healthcare utilization and patients' (unpaid) productivity losses [Baseline (T0) - One year post-randomisation (T4)]

    Patients' healthcare utilization and patients' (unpaid) productivity losses will be measured using cost questionnaires. There will be made use of retrospective 3-month cost questionnaires to avoid recall bias. Healthcare utilization will be valued using Dutch standards costs (56). If these are unavailable, prices reported by professional organizations will be used. will be valued in accordance with the "Dutch Manual of Costing".

  6. Compliance to the RISE intervention [Three months post-randomisation (T1)]

    Compliance to the treatment protocol will be measured with a questionnaire filled out by the physical therapists. Compliance consists of 1) the number of people that completed the intervention (with and without missing sessions); 2) The number of participants that mist one or more of the face to face sessions, the reasons for missing, and the percentage of missed sessions per participant; 3) The amount of sessions the participatory support was present; 4) The average amount of times participants used the RISE eCoaching system per week

  7. Safety during the RISE intervention and follow-up measurements. [Baseline (T0) - One year post-randomisation (T4)]

    Safety will be objectified by the number of adverse events registered by the researcher during the intervention and/or during the follow-up measure following the registration process.

  8. Health Related Quality of Life [Baseline (T0) - One year post-randomisation (T4)]

    Health Related Quality of Life will be measured with the questionnaire: EuroQol-5D (EQ-5D). This questionnaire comprises of 5 dimensions i.e., mobility, self-care, usual activities, pain/discomfort and anxiety/depression. Per dimension, patients are asked to indicate their health status on a 5-point Likert scale (1 = no problems; 5 = extreme problems). The health states can be converted into utility units by means of the Dutch rates. Utilities represent quality of life into a single number that ranges from 0 (death) to 1 (full health). Quality Adjusted Life Years (QALY's) can subsequently be calculated by multiplying the patients' utilities by the duration of time they spent in that particular health status.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:

In order to be eligible to participate in the baseline measurement of the intervention study, a subject must meet all of the following criteria:

  1. Aged 18 years or older;

  2. All types of first-ever stroke diagnosed in hospital within six months before start of the RISE intervention;

  3. Able to walk independently, as defined by a Functional ambulation categories score of at least 3;

  4. Independent regarding activities of daily living pre-stroke, as defined by a Barthel Index score of >18;

  5. Discharged to the home-setting;

  6. Not participating in a physical rehabilitation program lasting ≥ 3 months;

  7. Given their written informed consent.

Exclusion Criteria:
A potential subject will be excluded from participation in this study if:
  1. The participant has insufficient knowledge or is cognitively unable to understand the Dutch language of the intervention content;

  2. The participant has severe comorbidities that withhold that person from safely reducing and interrupting their sedentary time (e.g. sever pulmonary diseases, hart failure or malignity's) as determined with the Physical Activity Readiness Questionnaire;

Contacts and Locations

Locations

Site City State Country Postal Code
1 Fysiofit Vught Vught Brabant Netherlands 5262 GJ
2 Fysio 4 Den Bosch 's-Hertogenbosch Noord-Brabant Netherlands 5212 VJ
3 Meras & Vital Fysiotherapie Eersel Noord-Brabant Netherlands 5521 JJ
4 PMC Eindhoven Eindhoven Noord-Brabant Netherlands 5623 BB
5 Stroomz Prinsejagt Eindhoven Noord-Brabant Netherlands 5624 EA
6 Fysiotherapie Zesgehuchten Geldrop Noord-Brabant Netherlands 5663 PZ
7 JVDI De Fysioclub Helmond Noord-Brabant Netherlands 5707 CA
8 Fysiotherapie Rakthof Helmond Noord-Brabant Netherlands 5709 EK
9 Vivent Rosmalen Noord-Brabant Netherlands 5244 NJ
10 Van Hoof, centrum voor therapie en gezondheid Valkenswaard Noord-Brabant Netherlands 5554JV
11 Fysio Annette de Gooijer Vlijmen Noord-Brabant Netherlands 5251 RH
12 Fysio Vught Noord Vught Noord-Brabant Netherlands 5264PJ
13 Fysiotherapie Beelen Breukelen Utrecht Netherlands 3621 BJ
14 Fysiotherapie Zorgspectrum Houten eerstelijn Houten Utrecht Netherlands 3991 KZ
15 Fysiotherapie Groene Biezen Ijsselstein Utrecht Netherlands 3401 NG
16 MTCFysio Mijdrecht Utrecht Netherlands 3641 KJ
17 Rembrandt fysiotherapie en revalidatie Veenendaal Utrecht Netherlands 3904 JG
18 Fysio Frankenhof Wijk bij Duurstede Utrecht Netherlands 3962 CL
19 Synergy Fysiotherapie Woerden Utrecht Netherlands 3447 GM
20 Van Tongeren Fysiotherapeuten Zeist Utrecht Netherlands 3702 AD
21 Leidsche Rijn Julius Gezondheidscentra Utrecht Netherlands 3543 BZ

Sponsors and Collaborators

  • UMC Utrecht

Investigators

  • Principal Investigator: Martijn F Pisters, Dr., UMC Utrecht Brain Center and Fontys University of Applied Sciences

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Martijn F. Pisters, PhD, PT, Principal Investigator, UMC Utrecht
ClinicalTrials.gov Identifier:
NCT06124248
Other Study ID Numbers:
  • NL83940.000.23
  • RAAK.PRO04.093
First Posted:
Nov 9, 2023
Last Update Posted:
Nov 9, 2023
Last Verified:
Nov 1, 2023
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Martijn F. Pisters, PhD, PT, Principal Investigator, UMC Utrecht
Additional relevant MeSH terms:

Study Results

No Results Posted as of Nov 9, 2023